You have 9 free searches left this month | for more free features.

FBXW7 mutation

Showing 1 - 25 of 4,569

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Advanced Malignant Solid Tumor, EGFR Gene Amplification, EGFR Gene Mutation Trial in Houston (Everolimus, Neratinib,

Recruiting
  • Advanced Malignant Solid Neoplasm
  • +9 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 25, 2022

EGFR Exon 20 Mutation, ERBB2 Gene Mutation, Recurrent Lung Non-Small Cell Carcinoma Trial in Houston (Poziotinib)

Recruiting
  • EGFR Exon 20 Mutation
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 12, 2022

Metastatic Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage III Lung Non-Small Cell Cancer AJCC v7

Active, not recruiting
  • Metastatic Lung Non-Small Cell Carcinoma
  • +5 more
  • Laboratory Biomarker Analysis
  • +3 more
  • New Haven, Connecticut
  • +4 more
Jan 27, 2023

BRCA1 Gene Mutation, BRCA2 Gene Mutation, Ovarian Serous Adenocarcinoma Trial in Buffalo, New York (biological, other, drug)

Active, not recruiting
  • BRCA1 Gene Mutation
  • +5 more
  • Durvalumab
  • +3 more
  • Buffalo, New York
  • +1 more
Jan 20, 2023

BRCA1 Gene Mutation, BRCA2 Gene Mutation, Locally Advanced Solid Tumor Trial in New Brunswick, New York (Laboratory Biomarker

Recruiting
  • BRCA1 Gene Mutation
  • +19 more
  • Laboratory Biomarker Analysis
  • Pembrolizumab
  • New Brunswick, New Jersey
  • +1 more
Nov 16, 2022

Hematologic Malignancy, Acute Leukemia, Remission Trial (Fludarabine, Busulfan, Melphalan)

Not yet recruiting
  • Hematologic Malignancy
  • +21 more
  • (no location specified)
Feb 9, 2023

Acute Myeloid Leukemia, Mixed Lineage Acute Leukemia, Mixed Lineage Leukemia Gene Mutation Trial (Ziftomenib, Venetoclax,

Not yet recruiting
  • Acute Myeloid Leukemia
  • +10 more
  • (no location specified)
Feb 17, 2023

EGFR NP_005219.2:p.S492R, KRAS Gene Mutation, MAP2K1 Gene Mutation Trial in Houston (other, biological, drug)

Recruiting
  • EGFR NP_005219.2:p.S492R
  • +7 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 5, 2022

Space Occupying Lesions of the Brain

Recruiting
  • Brain Tumor
  • +2 more
  • MR-scans using a 3T Prisma and a 7T Terra scanner (Siemens, Erlangen Germany)
  • Bern, Switzerland
    Institute for Diagnostic and Interventional Neuroradiology, Univ
Jan 26, 2023

BRAF V600E Mutation Present, BRAF V600K Mutation Present, Metastatic Malignant Solid Tumor Trial in Boston (Dabrafenib,

Active, not recruiting
  • BRAF V600E Mutation Present
  • +9 more
  • Boston, Massachusetts
  • +1 more
Jun 28, 2022

People Who Have Genetic Changes and Features of Autism: Simons

Recruiting
  • 16P11.2 Deletion Syndrome
  • +184 more
    • New York, New York
    • +1 more
    Jan 6, 2023

    Acute Myeloid Leukemia, Relapsed Cancer, Refractory Cancer Trial in Edmonton, Toronto (Enasidenib, Venetoclax)

    Active, not recruiting
    • Acute Myeloid Leukemia
    • +3 more
    • Edmonton, Alberta, Canada
    • +1 more
    Jan 31, 2023

    BRCA1 Gene Mutation, BRCA2 Gene Mutation, Folate Receptor Alpha Positive Trial in Columbus (other, biological, drug)

    Active, not recruiting
    • BRCA1 Gene Mutation
    • +9 more
    • Laboratory Biomarker Analysis
    • +3 more
    • Columbus, Ohio
      Ohio State University Comprehensive Cancer Center
    Sep 16, 2022

    BRAF V600E Mutation Present, BRAF V600K Mutation Present, Metastatic Melanoma Trial in Boston (drug, biological, other)

    Terminated
    • BRAF V600E Mutation Present
    • +7 more
    • Boston, Massachusetts
    • +1 more
    Mar 9, 2022

    Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma, Prognostic Stage IV Breast Cancer AJCC v8 Trial in Houston

    Recruiting
    • Anatomic Stage IV Breast Cancer AJCC v8
    • +2 more
    • Houston, Texas
      M D Anderson Cancer Center
    Oct 25, 2022

    Metastatic Colon Carcinoma, Metastatic Colorectal Carcinoma, Metastatic Rectal Carcinoma Trial in United States (Laboratory

    Active, not recruiting
    • Metastatic Colon Carcinoma
    • +24 more
    • Laboratory Biomarker Analysis
    • +2 more
    • Corona, California
    • +7 more
    Oct 26, 2022

    Advanced Malignant Solid Tumor, Locally Advanced Malignant Solid Tumor Trial (drug, procedure, biological)

    Not yet recruiting
    • Advanced Malignant Solid Neoplasm
    • Locally Advanced Malignant Solid Neoplasm
    • (no location specified)
    Dec 2, 2022

    A P2X7R Single Nucleotide Mutation Promotes Chronic Allograft

    Completed
    • Cardiac Allograft Vasculopathy
      • Boston, Massachusetts
        Boston Children's Hospital
      Mar 2, 2021

      Melanoma, Brain Metastases Trial in Canada (Dabrafenib, Trametinib)

      Terminated
      • Melanoma
      • Brain Metastases
      • Halifax, Nova Scotia, Canada
      • +5 more
      Aug 18, 2021

      NSCLC, Lung Diseases, Lung Tumors Trial in New Haven (Sitravatinib, Pembrolizumab)

      Recruiting
      • Carcinoma, Non-Small-Cell Lung
      • +8 more
      • New Haven, Connecticut
        Yale University
      Oct 26, 2022

      Investigate Adaptation and Evolution of Ovarian High-grade

      Recruiting
      • Ovarian Cancer
      • +6 more
        • Bristol, United Kingdom
        • +10 more
        Sep 8, 2022

        Advanced Cancers Trial in Boston (LY2606368)

        Active, not recruiting
        • Advanced Cancers
        • Boston, Massachusetts
          Dana Farber Cancer Institute
        Jan 18, 2022

        KRAS Gene Mutation, Metastatic Malignant Tumor in the Brain, Recurrent Non-Small Cell Lung Carcinoma Trial in Palo Alto

        Active, not recruiting
        • KRAS Gene Mutation
        • +3 more
        • Palo Alto, California
          Stanford University School of Medicine
        Feb 9, 2022

        Locally Advanced or Metastatic Breast Cancer Trial in Canada, Israel, United States (Lasofoxifene, Fulvestrant)

        Active, not recruiting
        • Locally Advanced or Metastatic Breast Cancer
        • Phoenix, Arizona
        • +50 more
        Oct 24, 2022

        Early Development of Endometrial Carcinoma

        Recruiting
        • Cancer of Endometrium
          • Ferrara, Italy
            Section of Obstetrics and Gynecology, Department of Morphology,
          Apr 4, 2022